PROCEPT BioRobotics Corporation Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
PROCEPT BioRobotics Corporation (PRCT) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $604.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-08-05
- PROCEPT BioRobotics Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-06-30 was $409.00K, a 31.83% decline year-over-year.
- PROCEPT BioRobotics Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2026-03-31 was $195.00K, a 35.00% decline year-over-year.
- PROCEPT BioRobotics Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-12-31 was -$1.21M.
- PROCEPT BioRobotics Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-09-30 was $526.00K.
- PROCEPT BioRobotics Corporation accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2024 was $840.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $409.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $604.00K 10-Q · filed 2026-08-05 | -$603.00K derived: sum of 3 quarters · filed 2026-08-05 | -$77.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $195.00K 10-Q · filed 2026-04-30 | -$1.01M derived: sum of 2 quarters · filed 2026-08-05 | -$486.00K derived: sum of 3 quarters · filed 2026-08-05 | $114.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.21M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-05 | -$681.00K derived: sum of 2 quarters · filed 2026-08-05 | -$81.00K derived: sum of 3 quarters · filed 2026-08-05 | $219.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $526.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.13M derived: sum of 2 quarters · filed 2025-11-05 | $1.43M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $900.00K 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $300.00K 10-Q · filed 2025-05-02 | |||
| 2024-12-31 | $840.00K 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |